Clinical Trial Update: Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update comparing combination immunotherapy plus standard-of-care chemotherapy to standard chemotherapy alone for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING